These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 3742470)

  • 1. Endometrial adenocarcinoma. A multiparameter clinicopathologic analysis including the DNA profile and the sex steroid hormone receptors.
    Geisinger KR; Homesley HD; Morgan TM; Kute TE; Marshall RB
    Cancer; 1986 Oct; 58(7):1518-25. PubMed ID: 3742470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on steroid hormone receptors and hormone concentration and the results of DNA analysis by flow cytometry in endometrial carcinoma.
    Nola M; Jukić S; Ilić-Forko J; Babić D; Uzarević B; Petrovecki M; Suchanek E; Skrablin S; Dotlić S; Marusić M
    Gynecol Oncol; 1999 Mar; 72(3):331-6. PubMed ID: 10053103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cytoplasmic steroid receptor content on prognosis of early stage endometrial carcinoma.
    Creasman WT; Soper JT; McCarty KS; McCarty KS; Hinshaw W; Clarke-Pearson DL
    Am J Obstet Gynecol; 1985 Apr; 151(7):922-32. PubMed ID: 3985057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of quantitative pathologic features and DNA content in individual patients with stage I endometrial adenocarcinoma.
    van der Putten HW; Baak JP; Koenders TJ; Kurver PH; Stolk HG; Stolte LA
    Cancer; 1989 Apr; 63(7):1378-87. PubMed ID: 2920365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationships of the ploidy and cell cycle kinetics to differentiation and the female sex steroid hormone receptors in adenocarcinoma of the endometrium.
    Geisinger KR; Kute TE; Marshall RB; Homesley HD; Morgan TM
    Am J Clin Pathol; 1986 May; 85(5):536-41. PubMed ID: 3706195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoplasmic estrogen and progesterone receptors as prognostic parameters in primary endometrial carcinoma.
    Liao BS; Twiggs LB; Leung BS; Yu WC; Potish RA; Prem KA
    Obstet Gynecol; 1986 Apr; 67(4):463-7. PubMed ID: 3960417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of female sex steroid hormone receptors with histologic and ultrastructural differentiation in adenocarcinoma of the endometrium.
    Geisinger KR; Marshall RB; Kute TE; Homesley HD
    Cancer; 1986 Oct; 58(7):1506-17. PubMed ID: 3742469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative prognostic significance of DNA flow cytometry and histologic grading in endometrial carcinoma.
    Quillamor RM; Furlong JW; Hoschner JA; Wynn RM
    Gynecol Obstet Invest; 1988; 26(4):332-7. PubMed ID: 3229666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic correlation of DNA flow cytometric content analysis (DFCA), surgical staging, and estrogen/progesterone receptor status in endometrial adenocarcinoma.
    Konski AA; Domenico D; Irving D; Tyrkus M; Neisler J; Phibbs G; Mah J; Eggleston W
    Am J Clin Oncol; 1996 Apr; 19(2):164-8. PubMed ID: 8610642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of steroid receptor concentration and flow cytometrical DNA measurements in stage I-II endometrial carcinoma.
    Lindahl B; Alm P; Fernö M; Killander D; Långström E; Norgren A; Tropé C
    Acta Oncol; 1989; 28(4):595-9. PubMed ID: 2789839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic importance of steroid receptors in endometrial carcinoma.
    Palmer DC; Muir IM; Alexander AI; Cauchi M; Bennett RC; Quinn MA
    Obstet Gynecol; 1988 Sep; 72(3 Pt 1):388-93. PubMed ID: 3405554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of flow cytometry to clinical factors, hormone receptors, and histopathological grade in stage I and II invasive breast carcinoma.
    Haghbin M; McCue PA; Mansfield CM; Komarnicky LT; Benammar A; Schwartz GF
    Am J Clin Oncol; 1996 Feb; 19(1):54-8. PubMed ID: 8554037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Steroid receptors and clinical outcome in patients with adenocarcinoma of the endometrium.
    Ehrlich CE; Young PC; Stehman FB; Sutton GP; Alford WM
    Am J Obstet Gynecol; 1988 Apr; 158(4):796-807. PubMed ID: 2966586
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic significance of cell kinetic parameters of endometrial cancer].
    Kühn W; Kaufmann M; Feichter GE; Rummel HH; Abel U; Heep J; von Minckwitz G
    Geburtshilfe Frauenheilkd; 1989 Sep; 49(9):787-92. PubMed ID: 2806852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of estrogen receptor status on survival in patients with endometrial cancer.
    Martin JD; Hähnel R; McCartney AJ; Woodings TL
    Am J Obstet Gynecol; 1983 Oct; 147(3):322-4. PubMed ID: 6624797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA ploidy analysis of endometrial adenocarcinoma using a flow cytometry from paraffin-embedded tissues.
    Takahashi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Oct; 42(10):1339-44. PubMed ID: 1700035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of estrogen and progesterone receptors with histologic differentiation in endometrial adenocarcinoma.
    McCarty KS; Barton TK; Fetter BF; Creasman WT; McCarty KS
    Am J Pathol; 1979 Jul; 96(1):171-83. PubMed ID: 464018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical correlates of estrogen- and progesterone-binding proteins in human endometrial adenocarcinoma.
    Creasman WT; McCarty KS; Barton TK; McCarty KS
    Obstet Gynecol; 1980 Mar; 55(3):363-70. PubMed ID: 7189047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of flow cytometry for the prognosis of stage II adjuvant treated breast cancer patients.
    Kute TE; Muss HB; Cooper MR; Case LD; Buss D; Stanley V; Gregory B; Galleshaw J; Booher K
    Cancer; 1990 Oct; 66(8):1810-6. PubMed ID: 2208036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of steroid hormone receptor content and flow cytometric DNA ploidy in endometrial carcinoma.
    Grénman SE; Klemi P; Toikkanen S; Irjala K; Laippala P; Vähä-Eskeli K; Mäenpää J; Salmi T
    Ann Chir Gynaecol Suppl; 1994; 208():10-4. PubMed ID: 8092757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.